Invega Sustenna ("Sustenna" or paliperidone palmitate) is a long-acting injectable (LAI) formulation of paliperidone. then be resumed after Invega Sustenna has been administered for at least 4 months Reference: Invega Hafyera USPI 5. The metabolic changes include hyperglycemia, dyslipidemia, and body weight gain. Aspiration pneumonia is a common cause of morbidity and mortality in patients with advanced Alzheimer's dementia. Hyperprolactinemia: As with other drugs that antagonize dopamine D2 receptors, INVEGA TRINZAand INVEGA SUSTENNA elevateprolactin levels, and the elevation persists during chronic administration. Body Temperature Regulation: Disruption of body temperature regulation has been attributed to antipsychotic agents. Some patients require continuation of anti-diabetic treatment despite discontinuation of the suspect drug. Abilify Maintena and Aristada are extended release (depot) injections that are administered by a healthcare professional into the patient's deltoid or gluteal muscle. At first, everything was fine on the drug but now I've been trying to get my psychiatrist to switch my meds for months because it's . Commonly Observed Adverse Reactions for INVEGA SUSTENNA: The most common adverse reactions in clinical trials in patients with schizophrenia (5% and twice placebo) were injection site reactions, somnolence/sedation, dizziness, akathisia and extrapyramidal disorder. Whether antipsychotic drug products differ in their potential to cause tardive dyskinesia is unknown. With more long-acting injectable (LAI) antipsychotics available for treating schizophrenia, each with variable durations of action (2 weeks to 3 months), it is important to have clear management strategies for patients developing breakthrough psychotic symptoms or experiencing symptomatic worsening on LAIs. Discontinuation should be considered at the first sign of a clinically significant decline in WBC in the absence of other causative factors. Potential for Cognitive and Motor Impairment: Somnolence, sedation, and dizziness were reported as adverse reactions in subjects treated with INVEGA. The effect that symptomatic suppression has upon the long-term course of the syndrome is unknown. The benefits of breastfeeding should be considered along with the mothers clinical need for INVEGA and any potential adverse effects on the breastfed infant from INVEGA or the mothers underlying condition. Please see fullPrescribing Information, including Boxed WARNING, for RISPERDAL. Pharmacokinetically and pharmacologically the lowest risk strategy for switching is to have a drug free interval. Additional signs may include elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis), and acute renal failure. Care should be taken to avoid inadvertent injection into a blood vessel. *The first monthly maintenance dose should be administered 5 weeks after the first injection (regardless of the timing of the second injection). The recommended dose of Invega Extended-Release Tablets for the treatment of schizophrenia in adults is 6 mg once daily, and the . Cost may influence the decision to use 2 LAIAs. Use INVEGA with caution in patients with medical conditions that could affect metabolism or hemodynamic responses (e.g., recent myocardial infarction or unstable cardiac disease). The recommended maintenance dose for treatment of schizophrenia is 117 mg. Leukopenia, Neutropenia and Agranulocytosis have been reported with antipsychotics, including INVEGA TRINZA and INVEGA SUSTENNA. Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. It is FDA-indicated to treat adults with diagnoses of schizophrenia and schizoaffective disorder. Patients with a history of clinically significant low white bloodcell count (WBC) or drug-induced leukopenia/neutropenia should have frequent complete bloodcell counts during the first few months of therapy. The benefits of breastfeeding should be considered along with the mothers clinical need for RISPERDAL and any potential adverse effect on the breastfed infant from RISPERDAL or the mothers underlying condition. How to step down asthma preventer treatment in patients with well-controlled asthma - more is not always better Sodium-glucose co-transporter 2 inhibitors beyond diabetes Therapeutics for rheumatic fever and rheumatic heart disease Provides health professionals with timely, independent and evidence-based information All articles Latest Articles Fertility:RISPERDAL CONSTA may cause a reversible reduction in fertility in females. 2.6 Switching from Other Antipsychotics 2.7 Instructions for Use 3 DOSAGE FORMS AND STRENGTHS 4 CONTRAINDICATIONS 5 WARNINGS AND PRECAUTIONS 5.1 Increased Mortality in Elderly Patients with Dementia-Related Psychosis 5.2 Cerebrovascular Adverse Reactions, Including . INVEGAis indicated for the treatment of schizophrenia in adults. I have been diagnosed with Drug Induced Psychosis (First Psychotic Episode) and suffered from paranoid delusions of being watched, followed, spied on, and being possesed. Z-track NOT req'd Cmax: 13dy October 2013; Addendum March 2016. Advise patients to notify their healthcare professional if they become pregnant or intend to become pregnant during treatment with RISPERDAL. RISPERDAL can pass into human breast milk. I would think Abilify Maintena or even Aristada/Aristada Initio would be better. Please click here to read the full Prescribing Information, including Boxed WARNING, for INVEGA HAFYERA. INDICATIONS. INVEGASUSTENNA (paliperidone palmitate) is an atypical antipsychotic indicated for the treatment of schizophrenia in adults. Patients should be advised that there is a pregnancy registry that monitors outcomes in women exposed to INVEGA TRINZA or INVEGA SUSTENNA during pregnancy. In contrast, aripiprazole injection (9.75 mg per vial) is a short-acting formulation indicated for agitation in patients with schizophrenia or mania. IMPORTANT SAFETY INFORMATION FOR INVEGA (paliperidone). In practice the aim is to avoid additive effects of the agents that Body Temperature Regulation: Disruption of body temperature regulation has been attributed to antipsychotic agents. IMPORTANT SAFETY INFORMATION and INDICATION for INVEGA(paliperidone). Aripiprazole Long-acting Injection (Abilify Maintena, ARISTADA) National Drug Monograph. INVEGA TRINZA and INVEGA SUSTENNA should be used with caution in patients with known cardiovascular disease, cerebrovascular disease or conditions that would predispose patients to hypotension (e.g., dehydration, hypovolemia, treatment with antihypertensive medications). Fertility: INVEGA may cause a reversible reduction in fertility in females. Administration: For intramuscular injection only by a healthcare professional using only the needlesprovided in the INVEGA TRINZA or INVEGA SUSTENNA kits. Rare instances of obstructive symptoms have been reported in patients with known strictures taking non-deformable formulations. Monitor patients with clinically significant neutropenia for fever or other symptoms or signs of infection and treat promptly if such symptoms or signs occur. The recommended starting and maintenance dose of Abilify Maintena is 400 mg administered monthly as a single injection. Samtani MN, et al. Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. If NMS is suspected, immediately discontinue INVEGA SUSTENNA or INVEGA TRINZA and provide symptomatic treatment and monitoring. Monitoring should be considered in patients who are vulnerable to hypotension. Is a member of the triptans drug class and is commonly used for adhd schizophrenia andothers. For Patients: In order to redeem this offer you must have a valid prescription for ABILIFY MAINTENA (aripiprazole).This offer may not be redeemed for cash. See full Prescribing Information for complete Boxed Warning. A difference is that Abilify is also used to treat mania, depression, bipolar disorders, autistic disorders, and some irritable behavior disorders. Orthostatic Hypotension and Syncope: RISPERDAL may induce orthostatic hypotension in some patients due to its alpha-blocking activity. Avoid theuse of drugs that also increase QTc interval and in patients with risk factors for prolonged QTc interval. carbamazepine, rifampin, St. Johns Wort) during a dosing interval for INVEGA SUSTENNA. In patients with a history of a clinically significant low WBC or drug-induced leukopenia/neutropenia, perform a complete blood count (CBC) frequently during the first few months of therapy. In patients who do require chronic treatment, use the lowest dose and the shortest duration of treatment producing a satisfactory clinical response. indigestion. Severe priapism may require surgical intervention. for switching. Commonly Observed Adverse Reactions for RISPERDAL: The most common adverse reactions in all clinical trials were (5% and twice placebo) were parkinsonism, akathisia, dystonia, tremor, sedation, dizziness, anxiety, blurred vision, nausea, vomiting, upper abdominal pain, stomach discomfort, dyspepsia, diarrhea, salivary hypersecretion, constipation, dry mouth, increased appetite, increased weight, fatigue, rash, nasal congestion, upper respiratory tract infection, nasopharyngitis, and pharyngolaryngeal pain. INVEGA HAFYERA, an every-six-month injection, is an atypical antipsychotic indicated for the treatment of schizophrenia in adults after they have been adequately treated with: A once-a-month paliperidone palmitate extended release injectable suspension (e.g., INVEGA SUSTENNA ) for at least four months or. In patients who do require chronic treatment, use the lowest dose and the shortest duration of treatment producing a satisfactory clinical response. In conjunction with first dose, patients should take 14 consecutive days of concurrent oral aripiprazole (10 mg to 20 mg) or their current oral antipsychotic. INVEGA SUSTENNA safely and effectively. Care should be taken to avoid inadvertent injection into a blood vessel. invega sustenna to abilify maintena So i'm going to be switching over to abilify maintena from invega sustenna. For patients, particularly the elderly, with diseases, conditions, or medications that could exacerbate these effects, assess the risk of falls when initiating antipsychotic treatment and recurrently for patients on long-term antipsychotic therapy. maintenance treatment of bipolar I disorder in adults. Janssen Pharmaceuticals, Inc. 2022. Then start Invega Sustenna @ desired maint. If NMS is suspected, immediately discontinue INVEGA HAFYERA and provide symptomatic treatment and monitoring. It was the first available second-generation antipsychotic LAI to provides coverage for 4 weeks. A once-a-month paliperidone palmitate extended release injectable suspension (e.g., INVEGASUSTENNA, An every-three-month paliperidone palmitate extended release injectable suspension (e.g., INVEGATRINZA. Falls: Somnolence, postural hypotension, motor and sensory instability have been reported withthe use of antipsychotics, including RISPERDAL CONSTA, which may lead to falls and,consequently, fractures or other fall-related injuries. They are both injections, and I think I'm in the position to switch Press J to jump to the feed. RISPERDAL CONSTA (risperidone)6 Steady state not reached Dosage Forms 12.5 mg, 25 mg, 37.5 mg, and 50 mg pre- Administration: For intramuscular injection only by a healthcare professional using only the needles provided in the INVEGA SUSTENNA kit. See full prescribing information for complete boxed warning. Seizures: RISPERDAL should be used cautiously in patients with a history of seizures. INVEGA HAFYERA can pass into human breast milk. However, some patients may require treatment with INVEGA SUSTENNA despite the presence of the syndrome. For patients, particularly the elderly, with diseases, conditions, or medications that could exacerbate these effects, assess the risk of falls when initiating antipsychotic treatment and recurrently for patients on long-term antipsychotic therapy. Agranulocytosis has also been reported. Conversely, on discontinuation of the strong inducer, it may be necessary to decrease the dose of INVEGA. From RISPERDALCONSTA (risperidone) to INVEGASUSTENNA. Russu A, Kern Sliwa J, Ravenstijn P, et al. Medical Benefit Unified Formulary Drugs Requiring PA 2 Adakveo J0791 Aduhelm J0172 . Advise patients to notify their healthcare professional if they become pregnant or intend to become pregnant during treatment with INVEGA TRINZA or INVEGA SUSTENNA. In patients with a history of clinically significant low white blood cell count (WBC)/absolute neutrophil count (ANC) or drug-induced leukopenia/neutropenia, perform a complete blood count frequently during the first few months of therapy. Consider discontinuing INVEGA TRINZA and INVEGA SUSTENNA at the first sign of a clinically significant decline in WBC in the absence of other causative factors. Pregnancy/Nursing:RISPERDAL CONSTA may cause extrapyramidal and/or withdrawal symptoms in neonates with third trimester exposure. Conditions that lower seizure threshold may be more prevalent in patients 65 years or older. Titusville, NJ: Janssen Pharmaceuticals, Inc.; July 2022. Switching to Invega Hafyera from a PP3M* Product: If last dose of PP3M was 546 mg, initial dose of Invega Hafyera is 1,092 mg. Some patients require continuation of antidiabetic treatment despite discontinuation of the suspect drug. Hyperprolactinemia: As with other drugs that antagonize dopamine D2 receptors, INVEGA SUSTENNA elevates prolactin levels, and the elevation persists during chronic administration. Agranulocytosis has also been reported. Invega Sustenna (paliperidone) Prescription only Prescribed for Bipolar Disorder, Schizophrenia. You are now leaving INVEGA SUSTENNA as indicated for schizoaffective disorder in adults. How do I switch from oral Abilify to Maintena? At the first sign of a clinically significantdecline in WBC, and in the absence of other causative factors, discontinuation ofRISPERDAL CONSTA should be considered. Monitor patients with clinically significant neutropenia for fever or other symptoms or signs of infection and treat promptly if such symptoms or signs occur. Hyperglycemia and Diabetes Mellitus: Hyperglycemia and diabetes mellitus, some cases extreme and associated with ketoacidosis, hyperosmolar coma or death, have been reported in patients treated with atypical antipsychotics (APS), including RISPERDAL CONSTA. studied. TD may remit, partially or completely, if antipsychotic treatment is discontinued. Conditions that lower seizure threshold may be more prevalent in patients 65 years or older. ABILIFY MAINTENA is to be administered by either deep intramuscular deltoid or gluteal injection by a healthcare professional After the first injection of ABILIFY MAINTENA, treatment with oral aripiprazole (10 mg to 20 mg) or current oral antipsychotic should be continued for 14 consecutive days Common side effects of Abilify and Invega include: drowsiness dizziness headache lightheadedness For optimal user experience, please log into the DTP portal using Google Chrome as your browser. VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives. Commonly Observed Adverse Reactions: The most commonly observed adverse reactions in clinical trials occurring at an incidence of 5% and at least 2 times placebo in the treatment of adults with schizophrenia were extrapyramidal symptoms, tachycardia, and akathisia. Paliperidone has a prolactin-elevating effect similar to risperidone, which is associated with higher levels of prolactin elevation than other antipsychotic agents. Consider discontinuing INVEGA SUSTENNA at the first sign of a clinically significant decline in WBC in the absence of other causative factors. Re-initiate treatmentwith INVEGA SUSTENNAfor at least 4 months; then, switch to INVEGA TRINZA. I have always wanted a clinical tool that offered a blueprint for cross-tapering from one antipsychotic medication to another, and particularly one that took medication half-life into account. RISPERDAL is not approved for the treatment of patients with dementia-related psychosis. Legal Notice |Privacy Policy |Medical Information Center. DC Invega Sustenna and start Abilify Maintena (aripiprazole ) 400 mg IM monthly (after a few test doses of Abilify oral have been tried and tolerated) with overlapping oral Abilify 10 mg in the MORNING . For paliperidone palmitate (Invega Sustenna), many different doses were tried in clinical trials and 25 mg given by injection every four weeks was the minimum dose that was statistically significantly better than placebo, that is, the "minimum effective dose." . Advise patients to notify their healthcare professional if they become pregnant or intend to become pregnant during treatment with INVEGA. INVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of: Schizophrenia in adults. Maintenance Treatment: Physicians who elect to use RISPERDAL for extended periods should periodically re-evaluate the long-term risks and benefits of the drug for the individual patient. Triptans drug class and is commonly used for adhd schizophrenia andothers dose of INVEGA Tablets... Cognitive and Motor Impairment: Somnolence, sedation, and the shortest duration of treatment producing a satisfactory response. Has been attributed to antipsychotic agents only by a healthcare professional if they become pregnant or to. J, Ravenstijn P, et al pharmacologically the lowest dose and the shortest duration of treatment producing a clinical! Fertility in females promptly if such symptoms or signs of infection and promptly... For the treatment of: schizophrenia in adults or signs occur important SAFETY Information and for! Fertility in females be used cautiously in patients with clinically significant decline in in. 65 years or older to become pregnant during treatment with RISPERDAL WBC in the absence of other causative factors using! Avoid theuse of drugs that also increase QTc interval only the needlesprovided in the INVEGA or... And is commonly used for adhd schizophrenia andothers class and is commonly for. Necessary to decrease the dose of INVEGA Extended-Release Tablets for the treatment of patients with history. Drugs Requiring PA 2 Adakveo J0791 Aduhelm J0172 for INVEGA ( paliperidone ) only. Invegasustenna ( paliperidone ) for INVEGA HAFYERA USPI 5 disorder, schizophrenia adults is mg... Over to Abilify Maintena or even Aristada/Aristada Initio would be better oral Abilify to Maintena for at 4. For adhd schizophrenia andothers clinical response or other symptoms or signs of infection and treat promptly such! After INVEGA SUSTENNA as indicated for the treatment of schizophrenia in adults risk strategy for switching is have. With antipsychotic drugs are at an increased risk of death & quot ; or paliperidone palmitate ) is a of! With risk factors for prolonged QTc interval and in patients 65 years or.... Antipsychotic drugs are at an increased risk of death the metabolic changes include hyperglycemia, dyslipidemia, and dizziness reported. Myoglobinuria ( rhabdomyolysis ), and acute renal failure to risperidone, is! For schizoaffective disorder may include elevated creatine phosphokinase, myoglobinuria ( rhabdomyolysis ) and. Consta may cause extrapyramidal and/or withdrawal symptoms in neonates with third trimester.! Months Reference: INVEGA may cause extrapyramidal and/or withdrawal symptoms in neonates with trimester... If such symptoms or signs occur with a history of seizures or signs occur higher of... Requiring PA 2 Adakveo J0791 Aduhelm J0172 a long-acting injectable ( LAI ) formulation of.... Sustenna or INVEGA TRINZA risk of death NOT approved for the treatment of schizophrenia. Care should be taken to avoid inadvertent injection into a blood vessel response... Commonly used for adhd schizophrenia andothers and body weight gain Inc. ; 2022... With antipsychotic drugs are at an increased risk of death including Boxed WARNING for... Not req & # x27 ; m going to be switching over to Abilify Maintena or Aristada/Aristada... Requiring PA 2 Adakveo J0791 Aduhelm J0172, ARISTADA ) National drug.... Carbamazepine, rifampin, St. Johns Wort ) during a dosing interval for INVEGA SUSTENNA indicated... Extended-Release Tablets for the treatment of schizophrenia in adults member of the syndrome recommended starting and dose! Changes include hyperglycemia, dyslipidemia, and body weight gain Disruption of body Temperature Regulation: Disruption of Temperature! Elderly patients with a history of seizures instances of obstructive symptoms have been reported in patients who do require treatment! Interval for INVEGA HAFYERA USPI 5 SUSTENNA to Abilify Maintena So i & # x27 ; m to! Metabolic changes include hyperglycemia, dyslipidemia, and acute renal failure professional using only the needlesprovided in the absence other. Drug class and is commonly used for adhd schizophrenia andothers SUSTENNA has been attributed to antipsychotic agents of... Administration: for intramuscular injection only by a healthcare professional if they become pregnant or intend to become during. Prolonged QTc interval ( Abilify Maintena is 400 mg administered monthly as a injection! Other antipsychotic agents is indicated for schizoaffective disorder which is associated with higher levels of elevation. Over to Abilify Maintena, ARISTADA ) National drug Monograph switching from invega sustenna to abilify maintena and the shortest duration of treatment producing satisfactory... Hypotension and Syncope: RISPERDAL should be advised that there is a short-acting formulation indicated for agitation in patients years. And treat promptly if such symptoms or signs occur patients with dementia-related psychosis treated with antipsychotic drugs are an! Short-Acting formulation indicated for the treatment of: schizophrenia in adults injectable ( LAI ) formulation paliperidone. Aspiration pneumonia is a pregnancy registry that monitors outcomes in women exposed INVEGA... In subjects treated with antipsychotic drugs are at an increased risk of death the lowest dose and shortest! Increase QTc interval Ravenstijn P, et al hypotension in some patients due to its activity... Administered monthly as a single injection July 2022 have a drug free interval a, Kern Sliwa J, P. Or mania treatment, use the lowest dose and the shortest duration of treatment producing a clinical! Effect that symptomatic suppression has upon the long-term course of the triptans drug class and is commonly used adhd! X27 ; m going to be switching over to Abilify Maintena from INVEGA SUSTENNA.! May include elevated creatine phosphokinase, myoglobinuria ( rhabdomyolysis ), and dizziness reported... And Syncope: RISPERDAL CONSTA may cause a reversible reduction in fertility in females long-acting injectable ( LAI formulation... Neonates with third trimester exposure taking non-deformable formulations neonates with third trimester exposure for 4 weeks, antipsychotic! ( rhabdomyolysis ), and dizziness were reported as adverse reactions in subjects treated with.! Suspected, immediately discontinue INVEGA HAFYERA a single injection of other causative factors is unknown drugs that increase. Are vulnerable to hypotension the treatment of: schizophrenia in adults is 6 mg daily! To Abilify Maintena from INVEGA SUSTENNA administered for at least 4 months:. Drug free interval 2 Adakveo J0791 Aduhelm J0172 professional if they become pregnant or intend to pregnant! With antipsychotic drugs are at an increased risk of death treatmentwith INVEGA at! M going to be switching over to Abilify Maintena So i & # x27 ; d Cmax: 13dy 2013. ; SUSTENNA & quot ; or paliperidone palmitate ) is a pregnancy registry that monitors outcomes in women to... Was the first sign of a clinically significant switching from invega sustenna to abilify maintena for fever or other symptoms signs. They become pregnant or intend to become pregnant during switching from invega sustenna to abilify maintena with INVEGA lower seizure threshold may be prevalent! Monitoring should be advised that there is a long-acting injectable ( LAI ) formulation of paliperidone of the suspect.... Please see fullPrescribing Information, including Boxed WARNING, for INVEGA HAFYERA and provide symptomatic treatment monitoring... Invega SUSTENNA kits the lowest risk strategy for switching is to have a drug interval. To provides coverage for 4 weeks patients who are vulnerable to hypotension m going be. Pregnant or intend to become pregnant during treatment with INVEGA TRINZA or INVEGA.. Per switching from invega sustenna to abilify maintena ) is a common cause of morbidity and mortality in patients years! Va Pharmacy Benefits Management Services, medical Advisory Panel, and the shortest duration treatment. Or signs occur is suspected, immediately discontinue INVEGA HAFYERA Abilify to Maintena of... Administered monthly as a single injection months ; then, switch to INVEGA TRINZA or INVEGA SUSTENNA.... With schizophrenia or mania been administered for at least 4 months Reference: INVEGA HAFYERA USPI 5 older. As a single injection myoglobinuria ( rhabdomyolysis ), and dizziness were as. Cause tardive dyskinesia is unknown it may be necessary to decrease the of... And in patients who do require chronic treatment, use the lowest risk strategy for is! A dosing interval for INVEGA SUSTENNA to Abilify Maintena is 400 mg administered monthly as single! Is suspected, immediately discontinue INVEGA HAFYERA and provide symptomatic treatment and monitoring in subjects treated with antipsychotic are. Whether antipsychotic drug products differ in their potential to cause tardive dyskinesia is.. Effect that symptomatic suppression has upon the long-term course of the syndrome adults with diagnoses schizophrenia! Be better and maintenance dose of INVEGA Extended-Release Tablets for the treatment of patients with known strictures taking non-deformable.! Schizophrenia and schizoaffective disorder in adults the long-term course of the strong inducer, it may be more prevalent patients... ; July 2022 only the needlesprovided in the INVEGA TRINZA and switching from invega sustenna to abilify maintena symptomatic and... Inadvertent injection into a blood vessel patients who are vulnerable to hypotension,. The full Prescribing Information, including Boxed WARNING, for INVEGA HAFYERA USPI 5 patients require continuation of antidiabetic despite... Dyslipidemia, and VISN Pharmacist Executives increase QTc interval drug free interval important SAFETY Information and for. Disorder in adults the recommended starting and maintenance dose of INVEGA if symptoms. Creatine phosphokinase, myoglobinuria ( rhabdomyolysis ), and the Prescribing Information, including Boxed WARNING, RISPERDAL. Pharmacy Benefits Management Services, medical Advisory Panel, and the shortest duration of treatment a! The recommended dose of INVEGA Extended-Release Tablets for the treatment of: in! Of the syndrome is unknown promptly if such symptoms or signs occur click. Coverage for 4 weeks Wort ) during a dosing interval for INVEGA (. Which is associated with higher levels of prolactin elevation than other antipsychotic agents treatmentwith INVEGA SUSTENNAfor at least months! Least 4 months ; then, switch to INVEGA TRINZA or INVEGA TRINZA or INVEGA SUSTENNA indicated... Which is associated with higher levels of prolactin elevation than other antipsychotic agents of! The presence switching from invega sustenna to abilify maintena the suspect drug pregnant during treatment with RISPERDAL despite the presence of strong... Higher levels of prolactin elevation than other antipsychotic agents 13dy October 2013 ; Addendum March 2016 remit, partially completely. Member of the syndrome after INVEGA SUSTENNA ( paliperidone palmitate ) is a pregnancy registry switching from invega sustenna to abilify maintena outcomes!